Taktaz F, Fontanella RA, Scisciola L, Pesapane A, Basilicata MG, Ghosh P, et al
[2,6] Also involve them for rapid regain, significant distress, binge patterns, loss-of-control eating, adverse effects particularly persistent gastrointestinal symptoms, or if peri-operative planning is relevant
2 Introduction/background: history of incretin mimetics medications GIP was the first incretin isolated and characterized in the 1970s though most modern therapies focus on GLP-1 [17]
However, if they are accompanied by severe abdominal pain, vomiting, diarrhea, or signs of infection, you should consult your healthcare provider to rule out underlying conditions
Clinical Medicine Insights: Case Reports